Cas:102185-33-1 Disodium 5-bromo-4-chloro-1H-indol-3-yl phosphate manufacturer & supplier

We serve Chemical Name:Disodium 5-bromo-4-chloro-1H-indol-3-yl phosphate CAS:102185-33-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Disodium 5-bromo-4-chloro-1H-indol-3-yl phosphate

Chemical Name:Disodium 5-bromo-4-chloro-1H-indol-3-yl phosphate
CAS.NO:102185-33-1
Synonyms:5-Bromo-4-chloro-3-indolyl phosphate,disodium salt,hydrate;X-Phosphate Disodium Salt;MFCD00036757;1H-Indol-3-ol, 5-bromo-4-chloro-, dihydrogen phosphate (ester), sodium salt (1:2);5-Bromo-4-chloro-3-indolyl phosphate;Disodium 5-bromo-4-chloro-1H-indol-3-yl phosphate;disodium,(5-bromo-4-chloro-1H-indol-3-yl) phosphate;Disodium 5-Bromo-4-chloro-3-indolyl Phosphate;5-Bromo-4-chloro-3-indolyl Phosphate Disodium Salt;Sodium 5-bromo-4-chloro-1H-indol-3-yl phosphate
Molecular Formula:C8H4BrClNNa2O4P
Molecular Weight:370.432
HS Code:29339190

Physical and Chemical Properties:
Melting point:300°C
Boiling point:580.2ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:98.02000
Exact Mass:368.854523
LogP:3.93170

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 5-Bromo-4-chloro-3-indolyl phosphate,disodium salt,hydrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Sodium 5-bromo-4-chloro-1H-indol-3-yl phosphate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,disodium,(5-bromo-4-chloro-1H-indol-3-yl) phosphate Use and application,5-Bromo-4-chloro-3-indolyl Phosphate Disodium Salt technical grade,usp/ep/jp grade.


Related News: Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. Disodium 5-bromo-4-chloro-1H-indol-3-yl phosphate manufacturer Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. Disodium 5-bromo-4-chloro-1H-indol-3-yl phosphate supplier The national airlines of Egypt, Qatar and Saudi Arabia have halted flights to and from China. Disodium 5-bromo-4-chloro-1H-indol-3-yl phosphate vendor Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. Disodium 5-bromo-4-chloro-1H-indol-3-yl phosphate factory At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content.